Medinotec Inc. (MDNC) stock: key figures, P/E, revenue and dividend

Health Care · ISIN US58500G1076

Price
5.00 USD
Market cap
58.78 m USD
P/E (2026)
73.98
P/S (2026)
6.04
Dividend yield
0.00 %
Net margin
8.17 %
Return on equity (ROE)
13.91 %
Return on assets (ROA)
11.66 %

Medinotec Inc. financials

Fiscal year20252026
Revenue9.11 m USD9.73 m USD
Gross profit4.86 m USD5.13 m USD
Operating income3.19 m USD1.09 m USD
EBIT1.12 m USD607,412.00 USD
Net income2.16 m USD794,502.00 USD

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Medinotec Inc.

Medinotec Inc. engages in the research and development, production, and sale of medical devices used in cardiology and airway-related procedures in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents; and distributes a range of cardiology and renal dialysis products. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. Medinotec Inc. was incorporated in 2021 and is headquartered in Johannesburg, South Africa.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.